Transdermal teriparatide pharmacokinetics, pharmacodynamics and tolerability in postmenopausal Japanese women

Trial Profile

Transdermal teriparatide pharmacokinetics, pharmacodynamics and tolerability in postmenopausal Japanese women

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Sep 2011

At a glance

  • Drugs Teriparatide; Teriparatide
  • Indications Osteoporosis; Postmenopausal osteoporosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 20 Sep 2011 Results presented at the 33rd Annual Meeting of the American Society for Bone and Mineral Research.
    • 27 Oct 2010 Positive results reported in a TransPharma Medical media release.
    • 27 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top